CRH is trading at $83.00, down 4.09%, ahead of its scheduled Q3 2026 results. - Results were scheduled before the U.S. market open on October 29, with a conference call at 8:00 a.m. ET. - Available coverage identified the report as upcoming but did not confirm results or a company announcement explaining the decline. Estimates anticipated $2.14 EPS and $11.72 billion in revenue. - Broader market signals were mixed and do not establish a clear explanation for CRH’s drop.